By evaluating their combined effects on cell viability, apoptosis, mitochondrial function, and cell-cycle regulation, we aimed to identify a strategy to enhance L-asparaginase efficacy while reducing its dose-related toxicities, thereby improving therapeutic outcomes in T-ALL. Here, ASPG is linked to acute lymphoblastic leukemia.